|10:00 AM - 11:00 AM JST|
|09:00 AM - 10:00 AM CST|
|08:00 PM - 09:00 PM ET|
|05:00 PM - 06:00 PM PT|
In this session, partners Kathleen Sanzo, Jacqueline Berman, and Nancy Yamaguchi, with associate Jitsuro Morishita, will explain how the biopharma industry is using AI to increase efficiencies during the drug development process, explore the legal and regulatory implications of AI’s application to clinical trials, and discuss the potential future of AI in the Food and Drug Administration’s drug and biologic divisions.
CLE credit: CLE credit in CA, CT, FL, IL, NJ (via reciprocity), NY, PA, TX, and VA is currently pending approval.